Unichem Laboratories Limited has informed the Exchange regarding a press release dated March 17, 2023, titled "Press release pertaining to the receipt of ANDA approval from the United States Food and Drug Administration (USFDA) for Unichem s Ranolazine Extended-Release Tablets, 500 mg, and 1000 mg.".